project id: TCGA-STAD; case submitter id: TCGA-BR-A4IU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 7.8; age at index: 34; days to birth: -12601; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1978; age at diagnosis: 12601; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 838.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 113; days to sample procurement: 0; initial weight: 1610.0; portion submitter id: TCGA-BR-A4IU-01A-22; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 80.0;